Skip to main content
. 2020 Jun 8;60(7):1325–1339. doi: 10.1111/head.13835

Table 2.

Change in Average Headache Days/Month Before Prescribed an Acute Treatment vs Now and Treatment Regimens in Insufficient Responders and Responders to Acute Treatment

  Insufficient Responders (N = 200) Responders (N = 383) Total (N = 583) P Value
Number of unique preventive treatment regimens, n (%) .085
0 60 (33.5) 141 (40.6) 201 (38.2) .112
1 62 (34.6) 126 (36.3) 188 (35.7) .704
2 36 (20.1) 58 (16.7) 94 (17.9) .335
3+ 21 (11.7) 22 (6.3) 43 (8.2) .033
Number of unique acute treatment regimens, n (%) .029
0 11 (5.6) 6 (1.6) 17 (3.0) .008
1 94 (47.7) 195 (52.4) 289 (50.8) .286
2 49 (24.9) 105 (28.2) 154 (27.1) .392
3+ 43 (21.8) 66 (17.7) 109 (19.2) .239
Number of unique triptans, n (%) .695
0 22 (11.0) 41 (10.7) 63 (10.8) .913
1 117 (58.5) 239 (62.4) 356 (61.1) .359
2 47 (23.5) 84 (21.9) 131 (22.5) .667
3+ 14 (7.0) 19 (5.0) 33 (5.7) .312
Change in average headache days/month before prescribed an acute treatment vs now, n (%) .008
Headache days increased 33 (17.8) 43 (11.8) 76 (13.8)  
Headache days decreased 97 (52.4) 240 (65.9) 337 (61.4)  
No change 55 (29.7) 81 (22.3) 136 (24.8)  

All calculations were based on nonmissing values. Bold font in the P values column indicates statistically significant.

Please note: these data are influenced by the inclusion of a 10% oversampling of patients who had failed at least one line of preventive treatment. P values were from chi‐square or Fisher’s exact test.